vimarsana.com
Home
Live Updates
Clearer Definitions of Added Benefit, Unmet Needs Could Improve EU Oncologic Drug Approval Process : vimarsana.com
Clearer Definitions of Added Benefit, Unmet Needs Could Improve EU Oncologic Drug Approval Process : vimarsana.com
Clearer Definitions of Added Benefit, Unmet Needs Could Improve EU Oncologic Drug Approval Process
Investigators emphasize the importance of firming a widely understood definition of unmet needs in cancer care due to their impact on drug approvals.
Related Keywords
Utrecht ,
Netherlands ,
United States ,
Lourenst Bloem ,
Francine Brinkhuis ,
Division Of Pharmacoepidemiology ,
European Medicines Agency ,
European Union ,
Utrecht Institute For Pharmaceutical Sciences ,
Clinical Pharmacology ,
Utrecht Institute ,
Pharmaceutical Sciences ,
Utrecht University ,
Clinical Therapeutics ,
Global Oncology ,
Oncology Drugs ,